Naomi Mizuno

1.4k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Naomi Mizuno is a scholar working on Oncology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Naomi Mizuno has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Genetics and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Naomi Mizuno's work include Drug Transport and Resistance Mechanisms (7 papers), Inflammatory Bowel Disease (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Naomi Mizuno is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Inflammatory Bowel Disease (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Naomi Mizuno collaborates with scholars based in Japan, Netherlands and United States. Naomi Mizuno's co-authors include Yuichi Sugiyama, Takuro Niwa, Hiroshi Nakase, Noriko Sato, Hiroyuki Kusuhara, Kiyomi Ito, Yuko Tsukamoto, Motohiro Kato, Kōji Chiba and Michiko Suzuki and has published in prestigious journals such as Pharmacological Reviews, Journal of Hepatology and Pharmaceutical Research.

In The Last Decade

Naomi Mizuno

15 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The influence of cytokines on the complex pathology of ulcerative colitis

2021 255 citations Hiroshi Nakase, Noriko Sato et al. Autoimmunity Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naomi Mizuno Japan	12	577	308	286	252	164	16	1.1k
Cindy Q. Xia United States	20	777 1.3×	281 0.9×	481 1.7×	307 1.2×	71 0.4×	47	1.4k
Yannick Parmentier France	18	583 1.0×	335 1.1×	265 0.9×	259 1.0×	52 0.3×	38	1.1k
Justina C. Calamia United States	19	275 0.5×	326 1.1×	346 1.2×	257 1.0×	191 1.2×	22	1.1k
Nghia Nguyen United States	19	382 0.7×	436 1.4×	589 2.1×	409 1.6×	94 0.6×	31	1.4k
David B. Buckley United States	17	397 0.7×	499 1.6×	420 1.5×	178 0.7×	62 0.4×	21	1.2k
Hongbing Wang United States	20	362 0.6×	655 2.1×	384 1.3×	127 0.5×	252 1.5×	55	1.4k
Leslie J. Dickmann United States	24	445 0.8×	721 2.3×	478 1.7×	185 0.7×	148 0.9×	41	1.7k
Olaf Schaefer Japan	14	515 0.9×	528 1.7×	362 1.3×	160 0.6×	62 0.4×	16	1.1k
Maria Karlgren Sweden	19	740 1.3×	567 1.8×	438 1.5×	299 1.2×	62 0.4×	31	1.4k
Mayumi Saeki Japan	23	722 1.3×	483 1.6×	730 2.6×	413 1.6×	101 0.6×	58	1.7k

Countries citing papers authored by Naomi Mizuno

Since Specialization

Citations

This map shows the geographic impact of Naomi Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Mizuno more than expected).

Fields of papers citing papers by Naomi Mizuno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Mizuno. The network helps show where Naomi Mizuno may publish in the future.

Co-authorship network of co-authors of Naomi Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Mizuno. A scholar is included among the top collaborators of Naomi Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Mizuno. Naomi Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Matsuoka, Katsuyoshi, Ataru Igarashi, Noriko Sato, et al.. (2025). Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims database. Intestinal Research. 24(1). 103–116.

Hibi∥, Toshifumi, Shunsei Hirohata, Tadakazu Hisamatsu, et al.. (2024). Real-World Safety and Effectiveness of Infliximab in 255 Patients with Intestinal, Neurological, and Vascular Behçet’s Disease: A Post-Marketing Surveillance. Advances in Therapy. 41(12). 4476–4497. 4 indexed citations

Hirayama, Daisuke, Satoshi Motoya, Toshifumi Ashida, et al.. (2023). Effectiveness and Factors Associated with Response to Golimumab in Japanese Patients with Ulcerative Colitis in Real Clinical Practice: The Phoenix Study. Inflammatory Intestinal Diseases. 8(3). 115–127. 4 indexed citations

Nakase, Hiroshi, et al.. (2021). The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmunity Reviews. 21(3). 103017–103017. 255 indexed citations breakdown →

Mizuno, Naomi, et al.. (2007). Human Organic Anion Transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) Transport Edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and Its Sulfate Conjugate. Drug Metabolism and Disposition. 35(8). 1429–1434. 30 indexed citations

Mizuno, Naomi, et al.. (2007). Evaluation of the Role of Breast Cancer Resistance Protein (BCRP/ABCG2) and Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in The Urinary Excretion of Sulfate and Glucuronide Metabolites of Edaravone (MCI-186; 3-Methyl-1-phenyl-2-pyrazolin-5-one). Drug Metabolism and Disposition. 35(11). 2045–2052. 44 indexed citations

Mizuno, Naomi & Takuro Niwa. (2005). Drug transporter studies in drug discovery and development. Folia Pharmacologica Japonica. 125(4). 200–206. 7 indexed citations

Mizuno, Naomi, Michiko Suzuki, Hiroyuki Kusuhara, et al.. (2004). IMPAIRED RENAL EXCRETION OF 6-HYDROXY-5,7-DIMETHYL-2-METHYLAMINO-4-(3-PYRIDYLMETHYL) BENZOTHIAZOLE (E3040) SULFATE IN BREAST CANCER RESISTANCE PROTEIN (BCRP1/ABCG2) KNOCKOUT MICE. Drug Metabolism and Disposition. 32(9). 898–901. 66 indexed citations

Kato, Motohiro, Kōji Chiba, Akihiro Hisaka, et al.. (2003). The Intestinal First-pass Metabolism of Substrates of CYP3A4 and P-glycoprotei—Quantitative Analysis Based on Information from the Literature. Drug Metabolism and Pharmacokinetics. 18(6). 365–372. 74 indexed citations

10.

Mizuno, Naomi, et al.. (2003). Impact of Drug Transporter Studies on Drug Discovery and Development. Pharmacological Reviews. 55(3). 425–461. 376 indexed citations

11.

Ito, Kiyomi, Kōji Chiba, Masato Horikawa, et al.. (2002). Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?. PubMed. 4(4). 53–60. 69 indexed citations

12.

Mizuno, Naomi & Yuichi Sugiyama. (2002). Drug Transporters: Their Role and Importance in the Selection and Development of New Drugs. Drug Metabolism and Pharmacokinetics. 17(2). 93–108. 60 indexed citations

13.

Mizuno, Naomi, et al.. (2001). . Pharmaceutical Research. 18(8). 1203–1209. 17 indexed citations

14.

Mizuno, Naomi, Yukio Kato, Yuki Izumi, Tatsuro Irimura, & Yuichi Sugiyama. (1998). Importance of hepatic first-pass removal in metastasis of colon carcinoma cells. Journal of Hepatology. 28(5). 865–877. 27 indexed citations

15.

Mizuno, Naomi, Yukio Kato, Yuki Izumi, et al.. (1998). Mechanism of initial distribution of blood-borne colon carcinoma cells in the liver. Journal of Hepatology. 28(5). 878–885. 17 indexed citations

16.

Inaba, Makoto, Yasuyuki Ohnishi, Hajime Ishii, et al.. (1997). Pharmacokinetics of CPT-11 in rhesus monkeys. Cancer Chemotherapy and Pharmacology. 41(2). 103–108. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact